Dapagliflozin and Metformin
Dapagliflozin and Metformin comes in 36 pill versions in our database, in 8 strengths, from 11 manufacturers. Check the imprint to tell them apart.
Dapagliflozin and Metformin pill images
2.5 mg / 1000 mg 1 pill
5 mg / 500 mg 7 pills
- N 15 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Orange, capsule, 20 mm Used for type 2 diabetes and heart failure
- D M 5 500 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Orange, capsule, 20 mm Used for type 2 diabetes and heart failure
- MD6 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Pink, capsule, 19 mm Used for type 2 diabetes and heart failure
- 1070 5 500 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Orange, oval, 20 mm Used for type 2 diabetes and heart failure
- L108 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Orange, capsule, 18 mm Used for type 2 diabetes and heart failure
- F27 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Orange, capsule, 20 mm Used for type 2 diabetes and heart failure
- DM1 Dapagliflozin and Metformin Hydrochloride 5 mg / 500 mg Orange, oval, 17 mm Used for type 2 diabetes and heart failure
5 mg / 850 mg 1 pill
5 mg / 1000 mg 9 pills
- 5 1000 1071 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- N 16 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- D M 5 1000 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- MD5 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- RL 59 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- L109 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Purple, oval, 20 mm Used for type 2 diabetes and heart failure
- F28 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- DM3 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Pink, oval, 21 mm Used for type 2 diabetes and heart failure
- 5 1000 Dapagliflozin and Metformin Hydrochloride 5 mg / 1000 mg Yellow, oval Used for type 2 diabetes and heart failure
10 mg / 500 mg 8 pills
- N 19 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, capsule, 20 mm Used for type 2 diabetes and heart failure
- D M 10 500 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, capsule, 20 mm Used for type 2 diabetes and heart failure
- MD7 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Brown, capsule, 19 mm Used for type 2 diabetes and heart failure
- RL 60 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, oval, 17 mm Used for type 2 diabetes and heart failure
- 1072 10 500 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, oval, 20 mm Used for type 2 diabetes and heart failure
- L110 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, capsule, 18 mm Used for type 2 diabetes and heart failure
- F29 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, capsule, 20 mm Used for type 2 diabetes and heart failure
- DM2 Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg Pink, oval, 17 mm Used for type 2 diabetes and heart failure
10 mg / 1000 mg 8 pills
- 1073 10 1000 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- N 25 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- D M 10 1000 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- MD4 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Brown, oval, 20 mm Used for type 2 diabetes and heart failure
- RL 61 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- L111 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- F26 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 20 mm Used for type 2 diabetes and heart failure
- DM4 Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg Yellow, oval, 21 mm Used for type 2 diabetes and heart failure
850 mg / 5 mg 1 pill
1000 mg / 5 mg 1 pill
What is Dapagliflozin and Metformin used for?
Dapagliflozin and Metformin is used for type 2 diabetes and heart failure.
- Medicine type
- Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label
Dapagliflozin and metformin hydrochloride extended-release tablets are a combination of dapagliflozin and metformin hydrochloride (HCl) extended-release, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dapagliflozin, when used as a component of dapagliflozin and metformin hydrochloride extended-release tablets, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:
- Sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression.
- CV death, hospitalization for heart failure, and urgent heart failure visit in patients with heart failure.
- Hospitalization for heart failure in patients with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.
Limitations of Use
- Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
- Because of the metformin hydrochloride component, the use of dapagliflozin and metformin hydrochloride extended-release tablets is limited to patients with type 2 diabetes mellitus for all indications.
- Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive therapy for kidney disease. Dapagliflozin and metformin hydrochloride extended-release tablets are not expected to be effective in these populations.
Pediatric use information is approved for AstraZeneca AB’s Xigduo ® XR (dapagliflozin and metformin hydrochloride) Extended-Release Tablets. However, due to AstraZeneca AB’s marketing exclusivity rights, this drug product is not labeled with that information.
From the FDA-approved label on DailyMed (published Sep 24, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.